PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio

New institution is now third-largest public research university in Texas

2025-09-01
(Press-News.org) SAN ANTONIO, Sept. 1, 2025 – UTSA and The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today merged to form The University of Texas at San Antonio (UT San Antonio), a premier global university that is deeply committed to making lives better for the communities it serves. As a merged institution, UT San Antonio now ranks as the third-largest public research university in Texas according to annual research expenditures, behind only Texas A&M University and the University of Texas at Austin.

UT San Antonio’s comprehensive enterprise now includes approximately 40,000 students, 17,000 employees and more than $486 million in annual research expenditures. Its growing endowment tops $1.3 billion. The merger joins two Carnegie R1 (“very high research activity”) universities, an elite designation reserved for the top 5% of research institutions in United States, and represents the nation’s largest integration of universities by total research dollars and endowment since 2013.

UT San Antonio will immediately deliver immense value to students, researchers, alumni and partners, said President Taylor Eighmy. He envisions it will serve as an exemplar for The University of Texas System, the state of Texas and the nation.

“We intentionally grounded UT San Antonio in excellence — excellence in education, healthcare, transdisciplinary research and discovery — to form a model public research university that is nimble, creative and unlike any other,” said Eighmy. “With that spirit of excellence, we’ve combined two distinguished Tier One institutions to form a new world-class university that champions social mobility, improves health and powers discovery to amplify our collective strengths and create impact at scale.”

UT San Antonio’s breadth and scope

Building on the rich history of UTSA and UT Health San Antonio, UT San Antonio will advance knowledge through teaching and learning, groundbreaking research and scientific innovation, exceptional patient care and deep community engagement.

Spanning 15 colleges and schools across six campuses, UT San Antonio now offers more than 320 highly competitive undergraduate and graduate degrees and certificates, one of the most comprehensive academic portfolios in the state. UT San Antonio students have access to an education of the highest quality in disciplines ranging from science, engineering, business, education, humanities, social sciences, architecture and the arts to biomedical sciences, medicine, public health, dentistry, nursing and other allied health professions.

The university’s academic and research programs are ranked among the top 3% worldwide, according to the Center for University World Rankings. The institution is also in the top 12% of colleges and universities in the nation for social mobility, according to The Wall Street Journal and College Pulse. Additionally, its Executive MBA program is ranked 3rd in the U.S. by CEO Magazine.

UT San Antonio includes UT San Antonio Health Science Center, the region’s only academic health center and a globally leading health sciences institution, ranked in the top 2.4% of universities worldwide in the 2025 Center for World University Rankings, reaffirming its position as a global leader in biomedical discovery and innovation. UT San Antonio’s Health Science Center is ranked 84th out of 5,868 healthcare institutions around the world and 38th in the United States in the 2025 Nature Index of healthcare institutions for research output. This places the institution among the top 2% of healthcare institutes globally.

UT Health San Antonio, the clinical and patient-care enterprise of UT San Antonio, sees more than 2.5 million patient visits each year and brings together expertise across more than 200 medical and dental specialties and subspecialties—addressing everything from common conditions to complex diseases that disproportionately affect Texans. Through this work, the institution delivers life-changing impact for individuals and families across South Texas’ 38-county region.

Each year, UT Health San Antonio educates and trains more than 1,015 residents, fellows, and trainees, creating a vital pipeline of skilled physicians to serve our communities. With a team of more than 1,400 physicians, medical providers, health professionals and researchers, the institution provides essential coverage and strengthens the healthcare workforce that supports the region’s major health care networks—including University Health and the Audie L. Murphy Memorial Veterans’ Hospital, part of the South Texas Veterans Health Care System (STVHCS).

These deeply integrated partnerships not only elevate the quality of patient care today but also ensure that the health needs of our rapidly growing region and state are met with innovation and expertise.

Building on its combined capabilities, UT San Antonio leaders envision rapid development of hands-on learning opportunities and new degree programs, much like the 2023 launch of a dual degree program in medicine and artificial intelligence, which was the first program of its kind in the United States.

“Synergies of expertise that come together allow us to innovate. That’s going to be available now to students, to faculty, to scientists, to graduate students across the spectrum of this new university,” said Francisco G. Cigarroa, MD, who serves as senior executive vice president for health affairs and health system of UT San Antonio. “A discovery that happens here, that improves the quality of life, not only improves the quality of life for our children or for our loved ones, but that translates to the population at large and it's going to have a global impact.”

Athletics remain key to UT San Antonio’s vibrant culture. In all 17 NCAA Division I sports, student-athletes will continue to compete as UTSA in the American Conference. The school’s beloved mascot, Rowdy the Roadrunner, also remains central to UT San Antonio’s university spirit and growing footprint.

Growing Texas’ economy

UT San Antonio is projected to have a $7 billion annual economic impact, energizing San Antonio’s $44.1 billion healthcare and biosciences sector, the city’s largest industry.

The university will play a critical role in advancing regional prosperity by fostering excellence, building a culture of service and creating transformative opportunities that keep graduates in Texas, fulfilling its promise to provide talent for industry’s most in-demand, future-forward jobs.

Institutional data shows that more than 90% of UTSA’s alumni enter and remain in the Texas workforce, and UT San Antonio graduates and trains the majority of South Texas’ doctors, nurses, dentists, allied health providers and biomedical scientists.

Building on that momentum, Eighmy says that UT San Antonio has the potential to become “one of the most consequential and forward-thinking universities in the United States.”

Cigarroa added, “UT San Antonio is going to enrich that culture that makes San Antonio – the region that we live in – not only the best place to raise a family but the best place to study and the best place to work. Education saves lives. For me, it’s the greatest public health initiative we can provide because we can transform one life that will change generations to come.”

An ambitious vision within reach

In addition to bringing about interdisciplinary synergies in research and educational opportunities for both students and faculty, today’s merger completion puts UT San Antonio on a very real path to becoming a premier institution with the characteristics of the elite members of the Association of American Universities.

“I cannot overstate the significance of what this new UT San Antonio will mean to Texas and the nation,” said UT System Board of Regents chairman Kevin Eltife. “This is and always will be about impact. It's about bringing together two institutions that complement each other - one with academics, research, the arts, and athletics and another that has all that you could ask for to make patients' lives better through health education, research, and clinical care.”

 

About UT San Antonio

The University of Texas at San Antonio (UT San Antonio) is a nationally recognized, top-tier public research university that unites the power of higher education, biomedical discovery, and healthcare within one visionary institution. As the third-largest public research university in Texas and a Carnegie R1-designated institution, UT San Antonio is a model of access and excellence—advancing knowledge, social mobility and public health across South Texas and beyond. 

UT San Antonio advances knowledge through teaching and learning, scientific innovation, patient care and community engagement. It serves approximately 40,000 students in 320 academic programs spanning science, engineering, medicine, health, liberal arts, AI, cybersecurity, business, education and more. Each year, it invests more than $486 million to advance research programs and generates an economic impact of $7 billion for Texas. In addition to being a nationally preeminent academic health center, the university serves more than 2.5 million patient visits annually through its comprehensive health system, UT Health San Antonio.

Learn about the many ways “We make lives better®” at www.utsa.edu and https://uthscsa.edu.

   



END


ELSE PRESS RELEASES FROM THIS DATE:

Helicobacter pylori screening after acute myocardial infarction

2025-09-01
About The Study: Among unselected patients with acute myocardial infarction, routine H pylori screening did not significantly reduce the risk of upper gastrointestinal bleeding. Corresponding Author: To contact the corresponding author, Robin Hofmann, MD, PhD, email robin.hofmann@ki.se. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. Embed this link to provide your readers ...

Solar Orbiter traces superfast electrons back to Sun

2025-09-01
The European Space Agency-led Solar Orbiter mission has split the flood of energetic particles flung out into space from the Sun into two groups, tracing each back to a different kind of outburst from our star. The Sun is the most energetic particle accelerator in the Solar System. It whips up electrons to nearly the speed of light and flings them out into space, flooding the Solar System with so-called ‘Solar Energetic Electrons’ (SEEs). Researchers have now used Solar Orbiter to pinpoint the source of these energetic electrons and trace what we see out in space back to what’s actually ...

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

2025-09-01
NAGOYA, Japan — In late September 2025, KIOXIA Iwate Corporation (Koichiro Shibayama CEO) will begin evaluating a GaN-based e-beam technology developed through joint research between Photo electron Soul Inc. (PeS; Takayuki Suzuki CEO), a Nagoya University startup, and the Amano–Honda Laboratory at Nagoya University. PeS has developed a next-generation electron gun specialized for GaN (gallium nitride) photocathodes and has demonstrated its effectiveness for semiconductor inspection and metrology (I&M), enabling electron microscopy of nanoscale transistors and high-aspect-ratio structures. These ...

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

2025-09-01
by Prof Heidi Newberg The Earth supports the only known life in the universe, all of it depending heavily on the presence of liquid water to facilitate chemical reactions. While single-celled life has existed almost as long as the Earth itself, it took roughly three billion years for multicellular life to form. Human life has existed for less than one 10 thousandth of the age of the Earth. All of this suggests that life might be common on planets that support liquid water, but it might be uncommon to find life that studies the universe and seeks to travel ...

Metformin changes blood metal levels in humans

2025-09-01
The widely used diabetes drug metformin changes blood metal levels in humans. The Kobe University study is an important step in understanding the drug’s many actions and designing better ones in the future. Metformin is the most widely prescribed diabetes drug in the world. Apart from lowering blood sugar levels, it is also known to have a broad range of beneficial side effects such as against tumors, inflammations and atherosclerosis. However, although it has been used for more than 60 years ...

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

2025-08-31
About The Study: Among patients without documented atrial arrhythmia recurrence after catheter ablation for atrial fibrillation, discontinuing oral anticoagulant therapy resulted in a lower risk for the composite outcome of stroke, systemic embolism, and major bleeding vs continuing direct oral anticoagulant therapy.  Corresponding Author: To contact the corresponding author, Boyoung Joung, MD, email cby6908@yuhs.ac. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please see the article for additional information, including other authors, author contributions and ...

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

2025-08-31
About The Study: Fractional flow reserve-guided complete revascularization during the index procedure resulted in a significant reduction in the composite of all-cause death, nonfatal myocardial infarction, any revascularization, and stroke at 1 year. This was mainly driven by reduced repeat revascularization.  Corresponding Author: To contact the corresponding author, Tobias F. S. Pustjens, MD, email t.pustjens@gmail.com. To access the embargoed study: Visit our For The Media website at this link ...

Participation of women in cardiovascular trials from 2017 to 2023

2025-08-31
About The Study: The findings of this study highlight both progress and persistent challenges in representation of women within cardiovascular trials. These gaps not only limit the generalizability of trial outcomes but also perpetuate inequities in evidence-based care for women with cardiovascular conditions.  Corresponding Author: To contact the corresponding author, Martha Gulati, MD, MS, email martha.gulati@csmc.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please see the article for ...

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

2025-08-31
About The Study: In patients with cardiometabolic heart failure with preserved ejection fraction, semaglutide and tirzepatide showed more than 40% risk reduction for the composite of hospitalization for heart failure or all-cause mortality compared with a placebo proxy. Tirzepatide showed no meaningful benefit over semaglutide. Corresponding Author: To contact the corresponding author, Nils Krüger, MD, email nkruger1@bwh.harvard.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please ...

Changes in biology of internal fat may be the leading cause of heart failure

2025-08-31
Heart failure with preserved ejection fraction (HFpEF) appears to develop as a result of changes in the biology of a person’s internal fat tissue, according to the Adipokine Hypothesis, a new way of understanding how fat may impact the heart. The hypothesis paper was published today in JACC, the flagship journal of the American College of Cardiology, and is being presented at ESC Congress 2025. The author of the paper is Milton Packer, MD, FACC, Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center at Dallas and Visiting Professor at Imperial College in London. “Up ...

LAST 30 PRESS RELEASES:

Combination of mini-camera and AI predicts recurrent heart attack

Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)

UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio

Helicobacter pylori screening after acute myocardial infarction

Solar Orbiter traces superfast electrons back to Sun

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

[Press-News.org] UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio
New institution is now third-largest public research university in Texas